Last $0.27 USD
Change Today 0.00 / 0.00%
Volume 100.0
FSPM On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

fusion pharm inc (FSPM) Snapshot

Open
$0.27
Previous Close
$0.27
Day High
$0.27
Day Low
$0.27
52 Week High
03/5/14 - $9.20
52 Week Low
06/2/14 - $0.09
Market Cap
1.5M
Average Volume 10 Days
10.4K
EPS TTM
--
Shares Outstanding
5.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FUSION PHARM INC (FSPM)

Related News

No related news articles were found.

fusion pharm inc (FSPM) Related Businessweek News

No Related Businessweek News Found

fusion pharm inc (FSPM) Details

FusionPharm, Inc. manufactures and sells a line of cultivation containers under the PharmPod brand name in the United States. Its PharmPods cultivation container system is used in the indoor plant cultivation. Fusion Pharm, Inc. also sells its PharmPod cultivation containers for use in cultivating various plants to businesses, universities, and individuals. The company was formerly known as Baby Bee Bright Corp. and changed its name to FusionPharm, Inc. in April 2011. Fusion Pharm, Inc. is based in Denver, Colorado.

4 Employees
Last Reported Date: 03/31/12

fusion pharm inc (FSPM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

fusion pharm inc (FSPM) Key Developments

Fusion Pharm, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2014

Fusion Pharm, Inc. reported earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported revenue of $305,000. The company had a net loss of $47,795 for the quarter, primarily attributable to the start up nature of its business and the scaling of the company's operations.

FusionPharm to Open Seattle Sales Center

FusionPharm, Inc. has leased space in Seattle's SoDo warehouse district in anticipation of opening its first Washington State design and sales center later this spring. The opening of company's Seattle location marks an important milestone for FusionPharm as the company begin to open sales centers in each new, major marketplace. The lease term begins April 1, and FusionPharm anticipates completion of construction activities in approximately 6 weeks.

Fusion Pharm, Inc. Reports Revenues Results for the Quarter Ended September 30, 2013

Fusion Pharm, Inc. announced that it posted 38% revenue growth, quarter to quarter, for the period ended September 30, 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FSPM:US $0.27 USD 0.00

FSPM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FSPM.
View Industry Companies
 

Industry Analysis

FSPM

Industry Average

Valuation FSPM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FUSION PHARM INC, please visit www.fusionpharminc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.